ProPharma Group and The Planet Group announce unified brand and expanded capabilities. Learn more >

Using Science to Achieve EMA Approval for a First-in-Class Indication

You’re developing a drug, biologic, or medical device product. Your end goal is to achieve successful interactions with the regulatory agencies, getting you to the next regulatory milestone. Developing a submission that is rooted in science increases your chances of obtaining regulatory approval for your product.

Learn how our regulatory experts helped one client obtain European Medicines Agency (EMA) approval for a first-in-class oncology indication using science as the driver of success.

Download Case Study

Contact Us

Your Business has Complex Challenges. ProPharma Group has Exceptional Solutions.

We partner with pharmaceutical, biotechnology, and medical device clients to tackle complex challenges. Contact us to learn how our experienced team can help ensure regulatory and development success throughout the product lifecycle.

Interested in gaining an industry edge? Let us help you stay up to date.

All fields are required.
There was a problem with your submission. Errors have been highlighted below.